INESS

The INDEPTH Effectiveness and Safety Studies of Anti-malarial Drugs in Africa (INESS) is an exciting new platform that aims to enable African researchers to carry out large Phase IV trials.  This will result in systematic, evidence-based reviews of the comparative effectiveness and safety of malaria drugs in many widely used drug classes, and to apply the findings to inform public policy and related activities in local settings.

INESS group

Prof Fred Binka
Principal Investigator
Dr. Bernhards Ogutu
Senior Clinical Trialist
Dr. Rita Baiden
Clinical Trialist
Accountant